X T L Biopharmaceuticals reported $-479K in EBIT for its fiscal quarter ending in December of 2024.





Ebit Change Date
Alaunos Therapeutics USD -1.01M 175K Mar/2026
Bioline Rx USD -2.34M 1.05M Mar/2026
Teva Pharmaceutical Industries USD 758M 181M Mar/2026
X T L Biopharmaceuticals USD -479K 19K Dec/2024